Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

12.22
Delayed Data
As of Feb 05
 -0.01 / -0.08%
Today’s Change
11.10
Today|||52-Week Range
41.97
-68.33%
Year-to-Date

Today’s Trading

Previous close12.23
Today’s open12.08
Day’s range11.68 - 12.28
Volume1,335,359
Average volume (3 months)2,077,400
Market cap$553.7M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-2.42%
Earnings growth (this year)-43.05%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-31.38%
P/E ratioNM
Price/Sales59.36
Price/Book2.04

Competitors

 Today’s
change
Today’s
% change
CTMXCytomX Therapeutics ...-0.73-4.72%
RVNCRevance Therapeutics...-0.86-4.44%
SCMPSucampo Pharmaceutic...-0.38-3.19%
EPZMEpizyme Inc-0.24-2.50%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)-$1.19
Annual revenue (last year)$9.8M
Annual profit (last year)-$135.8M
Net profit margin-1,391.71%

Profile

Sector
Health Technology
Industry
Biotechnology
Senior VP, Chief Executive &
Medical Officer
Edward M. Kaye
Senior VP, Chief Financial &
Accounting Officer
Sandesh Mahatme
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers